Vir expands partnership with Gates Foundation, adding $50M for HIV and malaria antibody research initiative

Just two days after the US bought 600,000 more doses of Vir and GSK’s Covid-19 antibody sotrovimab to guard against Omicron, Vir Biotechnology announced a partnership expansion with the Bill and Melinda Gates Foundation for its T-cell vaccine program.